The accumulation of plasma advanced oxidation protein products (AOPPs) is prevalent in chronic kidney disease. We previously showed that accumulation of AOPPs resulted in podocyte apoptosis and their deletion by a cascade of signaling events coupled with intracellular oxidative stress. The transmembrane receptor that specifically transmits the AOPPs' signals to elicit cellular activity, however, remains unknown. Using co-immunoprecipitation and immunofluorescence, we found that AOPPs colocalized and interacted with the receptor of advanced glycation end products (RAGE) on podocytes. Blocking RAGE by anti-RAGE immunoglobulin G or its silencing by siRNA significantly protected podocytes from AOPPs-induced apoptosis both in vitro and in vivo and ameliorated albuminuria in AOPPschallenged mice. AOPPs-induced activation of nicotinamide adenine dinucleotide phosphate oxidase and the excessive generation of intracellular superoxide were largely inhibited by anti-RAGE immunoglobulin G or RAGE siRNA. Moreover, blockade of RAGE decreased the activation of the p53/Bax/ caspase-dependent proapoptotic pathway induced by AOPPs. Thus, AOPPs interact with RAGE to induce podocyte apoptosis and this, in part, may contribute to the progression of chronic kidney disease.
The accumulation of plasma advanced oxidation protein products (AOPPs) is prevalent in chronic kidney disease. We previously showed that accumulation of AOPPs resulted in podocyte apoptosis and their deletion by a cascade of signaling events coupled with intracellular oxidative stress. The transmembrane receptor that specifically transmits the AOPPs' signals to elicit cellular activity, however, remains unknown. Using co-immunoprecipitation and immunofluorescence, we found that AOPPs colocalized and interacted with the receptor of advanced glycation end products (RAGE) on podocytes. Blocking RAGE by anti-RAGE immunoglobulin G or its silencing by siRNA significantly protected podocytes from AOPPs-induced apoptosis both in vitro and in vivo and ameliorated albuminuria in AOPPschallenged mice. AOPPs-induced activation of nicotinamide adenine dinucleotide phosphate oxidase and the excessive generation of intracellular superoxide were largely inhibited by anti-RAGE immunoglobulin G or RAGE siRNA. Moreover, blockade of RAGE decreased the activation of the p53/Bax/ caspase-dependent proapoptotic pathway induced by AOPPs. Thus, AOPPs interact with RAGE to induce podocyte apoptosis and this, in part, may contribute to the progression of chronic kidney disease. Chronic kidney disease (CKD) is a worldwide health problem, and the population of CKD patients is increasing rapidly. 1 The pathogenesis of CKD is characterized by widespread glomerulosclerosis and interstitial fibrosis. There is a growing body of literatures showing that podocyte loss is related to the increased proteinuria and contributes to the renal progression in both diabetic and nondiabetic CKD. [2] [3] [4] [5] [6] [7] [8] Therefore, exploring factors implicated in the pathogenesis of podocyte injury is of great importance to the development of new strategies for the treatment of CKD.
AOPPs are a family of oxidized, dityrosine-containing protein products generated during excessive production of oxidants and often carried by albumin in vivo. 9, 10 Accumulation of plasma AOPPs was first found in patients undergoing dialysis 9 and subsequently demonstrated in patients with diabetes 11, 12 and metabolic syndrome. 13 Clinical studies have shown that AOPPs level is a strong predictor for the prognosis of immunoglobulin-A nephropathy. 14 In experimental models, chronic accumulation of plasma AOPPs is associated with aggravated glomerulosclerosis in remnant kidney and diabetic nephropathy. 15, 16 These data indicate that AOPPs may not merely be a marker for oxidative stress, they are actually a new class of renal pathogenic mediators as well. 9, 14 Most recently, we demonstrated that AOPPs induce podocyte apoptosis and deletion via the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent, Rodox-sensitive signaling, for the first time, establishing a causative link between oxidative stress and podocyte loss. However, the transmembrane receptor that specifically transmits the signal of AOPPs to elicit cellular activity has not yet been addressed. Previous studies have shown that various scavenger receptors (SRs) such as RAGE (receptor of advanced glycation end products), SR class A, and CD36 are expressed on the surface of podocytes. [17] [18] [19] Marsche et al. 20, 21 and our group have shown that class B type I receptor (SR-BI) and RAGE mediate AOPP-induced inflammatory response in endothelial cells. [20] [21] [22] Thus, the present study was aimed to characterize the receptor responsible for AOPPs-induced podocytes apoptosis.
RESULTS

RAGE mediated AOPPs-induced apoptosis in cultured podocytes
To clarify which receptor on podocyte is responsible for AOPPs-induced podocyte apoptosis, we preincubated podocytes with various concentrations of anti-RAGE, anti-CD36, anti-SR class A, anti-LOX1, anti-AGE-R3, anti-SR-BI or anti-TLR4 antibody before AOPPs exposure. As shown in Figure 1a and b, Supplementary Figures S1 and S2 online, only anti-RAGE significantly blocked AOPPs-induced podocyte apoptosis. Preincubation with anti-RAGE antibody significantly abrogated the apoptotic effect of AOPPs in a dose-dependent manner with 70% reduction at 20 mg/ml concentration, whereas 20 mg/ml of nonimmune immunoglobulin G (IgG) had no detectable effect.
To further confirm the role of RAGE on AOPPs-induced podocyte apoptosis, we next knocked down endogenous RAGE expression using a RAGE-specific small interference RNA (siRNA). As shown in Figure 1c , RAGE siRNA reduced the RAGE protein expression by 60-70%. We then transfected RAGE siRNA or scramble siRNA into podocytes before AOPPs treatment. Flow cytometric analysis showed that RAGEspecific siRNA transfection resulted in a significant decrease in AOPPs-induced apoptosis as compared with scramble siRNA transfection (Figure 1d and Supplementary Figure S3 online). Similar result was obtained using terminal deoxyuridine nick-end labeling staining (TUNEL; (Figure 1e )).
To test whether AOPPs interact with RAGE on podocyte, we performed co-immunoprecipitation assay. As shown in Figure 1f , AOPPs were detected by anti-AOPPs antibody in the anti-RAGE immunoprecipitate in AOPPs-treated cells but not in control cells. The colocalization of AOPPs and RAGE on podocyte was further confirmed by co-immunofluorescence staining in AOPPs-treated cells ( Figure 1g ).
RAGE mediated AOPPs-induced intracellular superoxide generation in vitro
Our previous study has demonstrated that NAD(P)H oxidase-dependent O 2 À production is the key step of AOPPs-induced podocyte apoptosis. We thus examined whether this key step is mediated by RAGE. As shown in Figure 2a , AOPPs-induced O 2 À production could be blocked by both anti-RAGE antibody and RAGE siRNA transfection.
Similarly, AOPPs-induced activation of NAD(P)H oxidase, such as p47 phox phosphorylation, binding of p47 phox with p22 phox , and the expression of NADPH subunits p47 phox and gp91 phox , could be inhibited by blocking RAGE using either anti-RAGE IgG or RAGE siRNA transfection (Figures 2b and c) .
We previously demonstrated that AOPPs-induced NADPH oxidase-dependent O 2 À production could be blocked by total protein kinase C (PKC) inhibitor, 23 suggesting that PKC activation is the upstream event of NADPH oxidase activation. However, which isoform of PKC is responsible for this effect remains unclear. Therefore, we tested the effect of AOPPs on the phosphorylation of the main subunits of PKC such as PKCa, PKCb1, PKCb2, and PKCz. As shown in Figure 3a and b, AOPPs exposure significantly increased the phosphorylation of PKCa (Po0.01), but had no effect on the phosphorylation of PKCb1, PKCb2, and PKCz.
To test whether the activation of PKCa is mediated by RAGE, we pretreated podocytes with anti-RAGE or RAGE siRNA transfection before AOPPs exposure. As shown in Figure 3c and d, blocking RAGE dramatically attenuated AOPPs-induced PKCa phosphorylation, indicating that the effect of AOPPs on PKCa activation is mediated by RAGE.
RAGE mediated AOPPs-induced activation of p53/Bax/caspase-3 pathway in vitro
We previously demonstrated that AOPPS-induced podocyte apoptosis is associated with increased activity of the p53/Bax/ caspase-3 pathway. To examine whether AOPPS-induced activation of p53/Bax/caspase-3 pathway was RAGE dependent, we preincubated podocytes with anti-RAGE antibody or nonimmune IgG before AOPPs exposure. As shown in Figure 4a , AOPPs-enhanced expression of p53 and Bax proteins was dramatically inhibited by anti-RAGE antibody. Similar result was obtained when podocytes were transfected with specific RAGE siRNA ( Figure 4b) .
Similarly, AOPPs challenge resulted in increased cleaved caspase-3 followed by decrease in procaspase-3. The levels of intact 113-kDa poly (adenosine diphosphate-ribose) polymerase (PARP), a substrate of activated caspases, were decreased after AOPPs treatment, coincident with the appearance of 85-kDa PARP cleavage products (Figure 4c and d ). AOPPsenhanced expression of cleaved caspase-3 and PARP (85 kDa) could be blocked by anti-RAGE antibody or RAGE siRNA ( Figure 4c and d), suggesting that AOPPs-induced activation of proapoptotic pathway is mainly mediated by RAGE.
AOPPs enhanced RAGE expression on podocyte in vitro and in vivo
Previous studies have shown that RAGE expression is linked to the situations in which its ligands are abundant. 24, 25 We therefore examined the effect of AOPPs on RAGE expression in podoctyes. Podocytes were treated with indicated concentrations of AOPPs for 12 h. As shown in Figure 5a -d, AOPPs challenge significantly augmented RAGE expression in cultured podocytes at both mRNA and protein levels in a dose-and time-dependent manner.
To determine whether AOPPs could induce RAGE expression in vivo, normal C57BL/6 mice were administrated with intravenous injection of AOPPs modified mouse serum albumin (AOPPs-MSA) for 5 weeks. We first examined the effect of AOPPs on RAGE expression by western blot. As shown in Figure 5e , RAGE expression was significantly increased in AOPPs-challenged mice compared with control mice. We next examined the localization of RAGE using immunohistochemistry staining. Co-staining of RAGE with antibody against podocyte marker Wilms's tumor-1 indicated that increased RAGE expression was mainly localized on podocytes in AOPPs-challenged mice (Figure 5f ).
Blocking RAGE attenuated AOPPs-induced podocyte apoptosis and albuminuria in vivo
To determine the role of RAGE in AOPPs-induced podocyte apoptosis in vivo, normal C57BL/6 mice were administrated with intraperitoneal injection of anti-RAGE IgG at 5 mg/kg body weight or vehicle together with intravenous injection of AOPPs-MSA for 5 weeks. We first examined podocyte apoptosis using double-immunofluorescence labeling of Wilms's tumor-1 and TUNEL assay. AOPPs treatment resulted in a significant increase of podocyte apoptosis. Anti-RAGE treatment dramatically decreased the number of TUNEL-positive podocytes compared with vehicle control mice (Figure 6a and b). Likewise, AOPP-induced increase in urinary albumin excretion was significantly attenuated by RAGE blockade (Figure 6c ).
Blocking RAGE inhibited AOPPs-induced apoptotic signaling in vivo
Consistent with in vitro data, AOPPs-induced O 2 À production in renal cortex homogenates was blocked by anti-RAGE IgG (Figure 7a ). RAGE blockade inhibited AOPPs-induced À production was inhibited by RAGE neutralizing antibody or RAGE siRNA. O 2 À production in podocyte homogenates was determined using the lucigenin chemiluminescence method. (b) Podocytes were preincubated with anti-RAGE antibody or transfected with RAGE siRNA followed by incubation with 200 mg/ml of AOPPs-MSA for 30 min. Phosphorylation of p47 phox was assayed by immunoprecipitation using anti-p47 phox antibody followed by immunoblotting with antibody against phosphoserine. The interaction of p47 phox with p22 phox was determined by immunoprecipitation using anti-p22 phox antibody followed by immunoblotting with anti-p47 phox antibody. (c) Podocytes were preincubated with anti-RAGE antibody or transfected with RAGE siRNA followed by incubation with 200 mg/ml of AOPPs-MSA for 12 h and then the cell lysates were harvested. The protein level of p47 phox and gp91 phox was analyzed by western blot. Data are expressed as mean ± s.d. of three independent experiments. Analysis of variance, Po0.001, # Po0.05 vs. IgG-treated or scramble siRNA-transfected cells. AOPPs, advanced oxidation protein products; Ctrl, control; IB, immunoblot; Ig, immunoglobulin; IP, immunoprecipitation; RAGE, receptor of advanced glycation end products; siNC, scramble siRNA; siRNA, small interference RNA. overexpression of p47 phox and gp91 phox in renal cortex (Figure 7b ). Similarly, AOPPs-induced activation of p53/Baxcleaved caspase-3 pathway was significantly inhibited by anti-RAGE ( Figure 7c ). Taken together, these data demonstrated that AOPPs-induced proapoptotic signaling in podocyte was mediated by RAGE in vivo. DISCUSSION We previously demonstrated that AOPPs accumulation resulted in podocyte apoptosis and depletion, establishing a causative link between oxidative stress and podocyte injury. 23, 26 However, the transmembrane receptor that specifically transmits the signal of AOPPs remains unknown. In this study, we provided in vitro and in vivo evidence that RAGE plays a central role in AOPPs-induced podocyte apoptosis. Blocking RAGE inhibited AOPPs-induced activation of intracellular proapoptotic pathway and protected podocytes from apoptosis. To the best of our knowledge, this is the first study demonstrating that AOPPs trigger podocytes apoptosis through interaction with RAGE.
Our previous study demonstrated that accumulation of AOPPs induce podocytes apoptosis via a cascade of signaling events coupled with intracellular oxidative stress. AOPPs activate NADPH oxidase through a PKC-dependent pathway, thereby leading to an excessive generation of intracellular superoxide, which in turn promotes the classical p53/Bax/ caspase-dependent apoptosis pathway. 23 One fundamental issue to be addressed is exactly how AOPPs transmit their signals across the plasma membrane to elicit cellular activities. One can assume that this probably requires a transmembrane receptor for AOPPs. In this study, we provided several lines of evidence demonstrating that AOPPs-induced podocyte apoptosis is mainly mediated by RAGE. First, AOPPs interacted with RAGE and colocalized with RAGE in AOPPs-treated podocyte, suggesting that AOPPs might be ligands of RAGE. Second, blocking RAGE or knocking down the expression of RAGE significantly protected podocyte from AOPPs-induced apoptosis both in vitro and in vivo. Third, activation of apoptotic signaling triggered by AOPPs was largely inhibited by RAGE blockade. These observations support the hypothesis that activation of RAGE is a common pathway that transduces signals from the diverse biochemical and molecular species, leading to propagation of inflammation and cellular perturbation. 22, 27 The bioactive structure of AOPPs, which interact with RAGE, has not been defined yet and is in active study.
RAGE is a member of the IG superfamily and a multiligand signal-transduction receptor. The advanced glycation end products (AGEs), the first identified ligand of RAGE, have been implicated not only in diabetes but also in such settings as inflammation, hypoxia, and ischemia/ reperfusion injury. 28, 29 In addition to AGEs, RAGE interacts with at least four other classes of ligands: the S100/ calgranulins, high-mobility group box-1, amyloid-b peptide and other amyloid species, and Mac-1. 30 These classes of ligands are linked to diabetes, inflammation, chronic neurodegenerative disorders, tumors, and amyloidoses. 30, 31 Highly intriguing is the observation that podocyte is the principal RAGE-expressing cell in the glomerulus, with expression also noted in the endothelium. 17, 32 In this study, we found that interaction of AOPPs with RAGE triggered podocyte apoptosis. This is consistent with Marsche et al. 20 and our previous finding that AOPPs induce inflammation in endothelial cells through interacting with RAGE. [20] [21] [22] Supporting our results, AGEs, via a RAGE-dependent signaling in podocytes, lead to generation of monocyte chemoattractant peptide-1, production of transforming growth factor-b, and other matrix-modifying species. 33, 34 Pharmacological antagonism of RAGE or its genetic deletion imparts marked protection from podocyte effacement, albuminuria, and glomerular sclerosis in diseases models. 34, 35 These data provide evidence linking RAGE to the pathogenesis of renal diseases, particularly the diseases related to podocyte injury. Although one might posit that interaction of AOPPs with RAGE in podocyte is expected based on observation concerning interaction of RAGE with other oxidized proteins, this is the first study examining the interaction of AOPPs with RAGE on kidney cells. AOPPs exert their pathobiological effect via different receptors on renal cells. Previous studies showed that AOPPs are capable of using CD36, a class B transmembrane multiligand SR, for transmitting their signals in renal tubular epithelial cells 36 AOPPs can use RAGE and SR-BI for their signaling in endothelial cells. [20] [21] [22] It is noteworthy that both RAGE and SR-BI are expressed on endothelial cells, but the expression level of SR-BI on podocytes is very low (data not shown). Furthermore, anti-SR-BI antibody was not able to block AOPPs-induced podocytes apoptosis, suggesting that the receptors mediating AOPPs' effect could be cell-type specific. Therefore, it is important to determine in each situation the impact of AOPPs on the affected cells, as well as the ability to bind to cellular surface. Although present at low levels in homeostasis, RAGE expression is increased during disease. 28, 29, 37 RAGE expression is upregulated in situations in which its ligands are abundant. 24, 25 Immune/inflammatory disorder is another situation in which RAGE expression is enhanced. 38, 39 This study demonstrated that AOPPs accumulation upregulated expression of RAGE in vivo and in vitro. AOPPs accumulation in plasma and in renal tissue has been found in diabetic and non-diabetic CKDs. 9, [11] [12] [13] [14] [15] [16] [17] Meanwhile, the upregulation of RAGE has been demonstrated in diabetic kidney and lupus nephropathy, particularly in podocytes. 17 Therefore, the increased activity of AOPPs-RAGE axis may promote renal inflammation and sclerosis and thus accelerate the progression of renal diseases. Stopping the cycle of AOPPs-RAGEdependent stress in the glomerulus can hold significant promise in treating renal disease of varied etiologies.
MATERIALS AND METHODS AOPPs-MSA preparation
AOPPs-MSA were prepared in vitro by incubation of MSA (Sigma Chemical, St Louis, MO) with hypochlorous acid (Fluke, Buchs, Switzerland) in the absence of free amino acid/carbohydrates/lipids to exclude the formation of AGEs-like structures as previously described. 9, 23 Prepared samples were dialyzed against phosphate-buffered saline to remove free hypochlorous acid and passed through a DetoxiGel column (Pierce, Rockford, IL) to remove contaminated endotoxin. Endotoxin levels in the preparation were determined with the amebocyte lysate assay kit (Sigma, St Louis, MO) and were found to be below 0.025 EU/ml. The components of AGEs, including N e _(carboxylmethyl) lysine, pentosidine, pyridine, or glyoxal-, glycolaldehyde-, and glyceraldehyde-modified proteins were determined as described previously, 22, [40] [41] [42] [43] [44] and were found to be undetectable in the prepared samples.
RAGE and AOPPs monoclonal antibody preparation
Monoclonal antibodies against RAGE (Cloen B2-2) and AOPPs (Clone 3F2) were generated as described previously. 45, 46 Briefly, the recombinant extracellular domain (amino acid 23-342) of RAGE protein (rhRAE) or hypochlorous acid oxidative-human albumin were intraperitoneally injected to BALB/c mice. Mouse slenocytes were fused with mouse myeloma cells. Only hybridoma cells that secreted antibodies against RAGE and AOPP were cloned by successive limiting dilution. The ascites were purified by affinity chromatography using HiTrap protein G Hp (GE Healthcare Bioscience, Piscataway, NJ). The monoclonal antibody isotypes were determined using a Monoclonal Antibody Isotype Kit (Thermo Scientific Pierce, Rockford, IL). The prepared monoclonal anti-RAGE antibody (B2-2) specifically recognizes recombinant RAGE and natural RAGE expressed on cell surface. 45 We have examined the efficacy of B2-2 on blocking AOPPs-induced reactive oxygen species production on podocytes and macrophages. As shown in Supplementary Figure S4A and C online, B2-2 significantly inhibited AOPPs-induced reactive oxygen species production in a dose-dependent manner, and its efficacy was comparable with the anti-RAGE antibody purchased from R&D System (Minneapolis, MN; Supplementary Figure S4B and D online). As a neutralizing antibody, B2-2 has been shown to be able to block AGE-induced phosphorylation of moesin in endothelial cells 47 and AGE-induced CD83 expression in dendritic cells. 48 Cell culture and siRNA transfection Conditionally immortalized murine podocyte cell line was generously provided by Professor Peter Mundel (Sinai School of Medicine, New York) and cultured as described previously. 49 Experiments were performed using passages 10 to 18, growth-restricted, conditionally immortalized podocytes.
Oligonucleotide siRNA duplex was synthesized by Shanghai Gene Pharma (Shanghai, China). The sequence of mouse RAGE siRNA was 5 0 -GGUCAGAGCUGACAGUGAUTT-3 0 . The sequence of scramble siRNA was 5 0 -UUCUCCGAACGUGUCACGUTT-3 0 . The transfection of siRNA in podocytes was carried out with Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instruction.
Animal experiment
All animal experiments were approved by the Committee on Animal Experimentation of Southern Medical University, and performed in compliance with the university's Guidelines for the Care and Use of Laboratory Animals. Twenty-four male C57BL/6 mice weighting 19-20 g were housed in a standard environment with regular light/ dark cycles and free access to water and chow diet. The animals were randomly assigned into three groups (n ¼ 6 in each group) and received daily intravenous injection of vehicle (endotoxin-free phosphate-buffered saline, pH 7.4), AOPPs-MSA (50 mg/kg/d), or AOPPs-MSA (50 mg/kg/d) together with intraperitoneal injection of mouse anti-RAGE monoclonal antibody (B2-2), respectively. The RAGE antibody was dissolved in sterilized phosphate-buffered saline and injected in a volume of 0.5 ml, and was administered in an initial bolus dose of 300 mg followed by doses of 100 mg three times weekly. The animals were killed at the end of week 5 and the kidneys were collected after perfusion with 25 ml of ice-cold normal saline.
Western blot and immunoprecipitation
The interaction of AOPPs-MSA with RAGE, p47 phox with p22 phox and gp91 phox , and phosphorylated p47 phox in cultured podocytes were determined as previously described. 23, 50 The goat anti-mouse RAGE antibody was from R&D Systems, rabbit anti-mouse p22 phox goat anti-mouse gp91 phox antibody, rabbit anti-mouse p47 phox antibody, rabbit anti-mouse p47 phox antibody, anti-Bax mAb, anti-Bcl-2 mAb, anti-p-PKCb1 pAb (Thr-642), anti-PKCb1 pAb, anti-PKCb2 pAb, polyclonal rabbit anti-p47 phox and rabbit anti-gp91 phox were all from Santa Cruz (Santa Cruz, CA), rabbit anti-caspase-3 pAb, anti-PARP mAb, anti-PKCa pAb, anti-p-PKCz pAb (Thr-642), and anti-PKCz mAb were all from Cell Signaling Technology (Beverly, MA), anti-PKCa (phospho-T638) mAb, anti-p-PKCb2 pAb (phospho-T641) were from Abcam (Cambridge, MA), and anti-p53 mAb was from Oncogene (Cambridge, MA). Horseradish peroxidase-conjugated rabbit anti-phosphoserine antibody was from Stressgen Bioreagents (Victoria, BC, Canada) and the horseradish peroxidase-conjugated swine anti-rabbit or goat anti-mouse or rabbit anti-goat IgG was from Dako Cytomation (DakoCytomation, Glostrup, Denmark).
Immunofluorescence staining and immunohistochemistry
Podocytes cultured on coverslips were fixed with cold methanol/ acetone (1:1) for 10 min at À20 1C, followed by blocking with 20% normal donkey serum in phosphate-buffered saline with anti-AOPPs and goat anti-mouse RAGE antibody (R&D Systems) followed by incubating with Alexa Fluor 546-conjugated donkey anti-goat IgG and Alexa Fluor 488-conjugated chicken anti-mouse IgG. Nuclei were stained with 4,6-diamidino-2-phenylindole (Sigma Chemical) according to manufacturer's instruction. Images were taken by confocal microscopy (Leica TCS SP2 AOBS, Leica Microsystems, Buffalo Grove, IL).
The expression of RAGE in the kidney section was determined as described previously. 17 Briefly, the sections were co-stained by anti-RAGE (Santa Cruz) and Wilms's tumor-1 (ab89901, Abcam, Cambridge, UK) and then detected using the EnVision G|2 Doublestain System (Dako, Carpinteria, CA).
Real-time PCR
Total RNA was prepared using a TRIzol RNA isolation system (Life Technologies, Grand Island, NY) according to the manufacturer's instruction. The first strand of complementary DNA was synthesized using 1 mg of RNA in 20 ml of reaction buffer using MMLV-RT and random primers at 37 1C for 50 min. Real-time PCR was performed using a Plantinum SYBR Green qPCR SuperMix-UDG kit (Invitrogen). The primer sequences are as follows: mouse RAGE, 5 0 -ACAGGCGAGGGAAGGAGGTC-3 0 and 5 0 -TTTGCCATCGG-GAATCAGAAG-3 0 ; mouse glyceraldehyde-3-phosphate dehydrogenase, 5 0 -CCAATGTGTCCGTCGTGGAT-3 0 and 5 0 -TGCTGTTGAAGT CGCAGGAG-3 0 .
Assessment of podocyte apoptosis
Annexin V-labeled cells in cultured podocytes. Determination of Annexin V-labeled apoptotic cells was performed as described previously. 23 Podocytes were serum starved for 24 h and pretreated for 2 h at 37 1C with 2.5-20 mg/ml of goat anti-mouse RAGE neutralizing pAb (R&D Systems), 20 mg/ml of mouse anti-mouse CD36 [JC63.1] blocking mAb (Abcam), 20 mg/ml of goat antimouse SR class A neutralizing pAb (R&D Systems), 10 mg/ml of goat anti-mouse LOX1 neutralizing pAb (R&D Systems), 20 mg/ml of rat anti-mouse AGE-R3 capturing mAb (clone 202213; R&D Systems), SR-BI (NB400-113, Novus Biologicals, Littleton, CO) or 20 mg/ml of LEAF purified anti-mouse CD284 (TLR4) blocking antibody (Biolegend, San Diego, CA), respectively, before incubating with indicated amount of AOPPs-MSA for 24 h. Cells were trypsined and double stained with fluorescein isothiocyanateconjugated Annexin V and propidium iodide according to the manufacturer's instructions (Roche, San Francisco, CA). Cells were analyzed using a flow cytometer (BD FACS Calibur System, Franklin Lakes, NJ).
TUNEL assay. DNA strand breaks in cultured podocytes were identified using the in situ nick/end-labeling assay (TUNEL) as described previously. 23 NADPH-dependent superoxide (O 2 À ) production NADPH-dependent O 2 À production by homogenates from cultured podocytes or renal cortex was assessed by lucigenin-enhanced chemiluminescence as described previously. 23 Intracellular production of reactive oxygen species Intracellular reactive oxygen species was detected in podocytes and macrophages by analyzing the fluorescence intensity of the intracellular fluoroprobe 5-(6)-chloromethyl-2 0,70-dichlorodihydrofluorescein diacetate (Molecular Probe, Carlsbad, CA) using a fluorescent microplate reader at an excitation wavelength of 480 nm and an emission wavelength of 530 nm. Untreated cells were used to determine the background fluorescence. The final fluorescent intensity was normalized to the protein content. Data were expressed as percentage of controls (untreated cells).
Urine albumin assay
Urine albumin was measured by using a mouse Albumin ELISA quantitation kit, according to the manufacturer's protocol (Bethyl Laboratories, Montgomery, TX).
Statistical analysis
All experiments were performed in triplicate. Continuous variables, expressed as mean ± s.d., were compared using one-way analysis of variance. Pairwise comparisons were evaluated by the Student-Newman-Keuls procedure or Dunnett's T3 procedure when the assumption of equal variances did not hold. The Dunnett procedure was used for comparisons between reference group and other groups. Two-tailed P-value of less than 0.05 was considered statistically significant. Statistical analyses were conducted with SPSS 13.0, (SPSS Inc, Chicago, IL).
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